Detalles de la búsqueda
1.
NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet Oncol
; 19(6): 799-811, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29753703
2.
Phase II study of asparagine-glycine-arginine-human tumor necrosis factor alpha, a selective vascular targeting agent, in previously treated patients with malignant pleural mesothelioma.
J Clin Oncol
; 28(15): 2604-11, 2010 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20406925
3.
Apoptosis promoted by up-regulation of TFPT (TCF3 fusion partner) appears p53 independent, cell type restricted and cell density influenced.
Apoptosis
; 11(12): 2217-24, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17041757
Resultados
1 -
3
de 3
1
Próxima >
>>